Global Iron Deficiency Anemia Treatment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Iron Deficiency Anemia Treatment Market Research Report 2024
People with iron deficiency and mild to moderate anemia are mainly treated with oral iron, and their diets should be improved to eat iron-rich foods. Severe anemia can be treated with oral iron or intravenous iron, as well as a small number of repeated infusions of packed red blood cells. However, intravenous iron supplementation is not recommended during the first trimester.
According to MRAResearch’s new survey, global Iron Deficiency Anemia Treatment market is projected to reach US$ 1136.6 million in 2033, increasing from US$ 899.4 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Iron Deficiency Anemia Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
AdvaCare Pharma
Akorn
Sun Pharmaceutical Industries Ltd.
Akebia Therapeutics, Inc.
Rockwell Medical, Inc.
Vifor Pharma Management Ltd.
Shield Therapeutics
AMAG Pharmaceuticals
Pharmacosmos A/S
Segment by Type
Ferrous Sulfate
Ferrous Gluconate
Ferrous Fumerate
Ferric Hydroxide
Sodium Ferric Gluconate
Iron Carbohydrates
Others
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Iron Deficiency Anemia Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to MRAResearch’s new survey, global Iron Deficiency Anemia Treatment market is projected to reach US$ 1136.6 million in 2033, increasing from US$ 899.4 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Iron Deficiency Anemia Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
AdvaCare Pharma
Akorn
Sun Pharmaceutical Industries Ltd.
Akebia Therapeutics, Inc.
Rockwell Medical, Inc.
Vifor Pharma Management Ltd.
Shield Therapeutics
AMAG Pharmaceuticals
Pharmacosmos A/S
Segment by Type
Ferrous Sulfate
Ferrous Gluconate
Ferrous Fumerate
Ferric Hydroxide
Sodium Ferric Gluconate
Iron Carbohydrates
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Iron Deficiency Anemia Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source